Back
Aptevo Therapeutics Vs. Trevi Therapeutics Industry Stock Comparison
Sell
14
APVO
Aptevo Therapeutics
Last Price:
4.10
Seasonality Move:
-34.13%
Buy
63
TRVI
Trevi Therapeutics
Last Price:
4.17
Seasonality Move:
36.58%
Sell
14
Aptevo Therapeutics (APVO)
is a Sell
Is Aptevo Therapeutics a Buy, Sell or Hold?
- The current Aptevo Therapeutics [APVO] share price is $4.09. The Score for APVO is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- APVO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
63
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy, Sell or Hold?
- The current Trevi Therapeutics [TRVI] share price is $4.17. The Score for TRVI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- TRVI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APVO Stock Price Chart
What is Aptevo Therapeutics's stock price today?
-
The Aptevo Therapeutics share price today is $4.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APVO is experiencing selling pressure, which indicates risk of future bearish movement.
TRVI Stock Price Chart
What is Trevi Therapeutics's stock price today?
-
The Trevi Therapeutics share price today is $4.17
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing buying pressure, which is a positive indicator for future bullish movement.
APVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.69 | Sell |
| Relative Strength Index (14 RSI): | 32.79 | Sell |
| Chaikin Money Flow: | -796984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.69 - 11.35) | Sell |
| Bollinger Bands (100): | (7.17 - 13.87) | Sell |
TRVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 73.93 | Buy |
| Chaikin Money Flow: | 2441105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.23) | Buy |
| Bollinger Bands (100): | (2.76 - 3.28) | Buy |
APVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.45 | Sell |
| 20-day SMA: | 9.45 | Sell |
| 50-day SMA: | 8.87 | Sell |
| 200-day SMA: | 38.37 | Sell |
| 8-day EMA: | 7.76 | Sell |
| 20-day EMA: | 8.92 | Sell |
| 50-day EMA: | 9.67 | Sell |
| 200-day EMA: | 177.43 | Sell |
TRVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.95 | Buy |
| 20-day SMA: | 2.88 | Buy |
| 50-day SMA: | 2.99 | Buy |
| 200-day SMA: | 2.94 | Buy |
| 8-day EMA: | 3.16 | Buy |
| 20-day EMA: | 2.98 | Buy |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 2.81 | Buy |
Aptevo Therapeutics Earnings Growth & APVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $11.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3,519.81 per share, and an increase next year of $64.38 per share.
Trevi Therapeutics Earnings Growth & TRVI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.00 per share.
Aptevo Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Trevi Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||